// App-Quantinova.ai

3648 : Clinical Use Of Anti-Xa Monitoring In Malignancy-Associated Thrombosis

Researchers

Presenter

  • Brandon McMahon

Principal Investigators

  • Sarah Yentz

  • Oluwatoyosi A. Onwuemene

  • Brady L. Stein

  • Elizabeth H. Cull

Medical Centers

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • Northwestern Feinberg School of Med., Chicago, IL

  • Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute Divison of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, IL

  • Feinberg School of Medicine, Northwestern University, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Venous thrombosis

  • Lung Cancer

  • Obesity

  • Solid malignancies

Biomarkers

  • Body mass index

Drug/Treatment

  • Heparin

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved